Approach to mitigate severe CRS/ICANS and progressive toxicities despite the optimal use of first-line therapies.
Figure 1.

Approach to mitigate severe CRS/ICANS and progressive toxicities despite the optimal use of first-line therapies.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal